Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abraham Fisher

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Molecular and Cellular Neurosciences|May 17, 2011
ERK1-independent α-secretase cut of β-amyloid precursor protein via M1 muscarinic receptors and PKCα/εMoustapha Cisse, Ursula Braun, Michael Leitges, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 13, 2007
M1 and M3 muscarinic receptors control physiological processing of cellular prion by modulating ADAM17 phosphorylation and activityMoustapha Alfa Cissé, Claire Sunyach, Barbara E Slack, et al.
Pharmacology, Biochemistry, and Behavior|November 1, 2003
Reduction in distractibility with AF102B and THA in the macaqueJoseph O'Neill, Douglas W Siembieda, K Casey Crawford, et al.
Neurobiology of Disease|October 12, 2004
M1 muscarinic receptor activation protects neurons from beta-amyloid toxicity. A role for Wnt signaling pathwayGinny G Farías, Juan A Godoy, Félix Hernández, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 2, 2018
AF710B, an M1/sigma-1 receptor agonist with long-lasting disease-modifying properties in a transgenic rat model of Alzheimer's diseaseHélène Hall, Maria Florencia Iulita, Palma Gubert, et al.
Neuron|March 1, 2006
M1 receptors play a central role in modulating AD-like pathology in transgenic miceAntonella Caccamo, Salvatore Oddo, Lauren M Billings, et al.
Journal of Alzheimer'S Disease : JAD|April 18, 2015
Acute Effects of Muscarinic M1 Receptor Modulation on AβPP Metabolism and Amyloid-β Levels in vivo: A Microdialysis StudyTobias Welt, Luka Kulic, Sarah E Hoey, et al.
Journal of Molecular Neuroscience : MN|September 6, 2002
AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's diseaseAbraham Fisher, Rachel Brandeis, Rachel Haring Nira Bar-Ner, et al.
Molecular and Cellular Neurosciences|August 30, 2008
Isoform-specific contribution of protein kinase C to prion processingMoustapha Alfa Cissé, Krystel Louis, Uschi Braun, et al.
EJNMMI Research|March 22, 2013
[11C]AF150(S), an agonist PET ligand for M1 muscarinic acetylcholine receptorsHans Jc Buiter, Albert D Windhorst, Marc C Huisman, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Molecular and Cellular Neurosciences|May 17, 2011
ERK1-independent α-secretase cut of β-amyloid precursor protein via M1 muscarinic receptors and PKCα/εMoustapha Cisse, Ursula Braun, Michael Leitges, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 13, 2007
M1 and M3 muscarinic receptors control physiological processing of cellular prion by modulating ADAM17 phosphorylation and activityMoustapha Alfa Cissé, Claire Sunyach, Barbara E Slack, et al.
Pharmacology, Biochemistry, and Behavior|November 1, 2003
Reduction in distractibility with AF102B and THA in the macaqueJoseph O'Neill, Douglas W Siembieda, K Casey Crawford, et al.
Neurobiology of Disease|October 12, 2004
M1 muscarinic receptor activation protects neurons from beta-amyloid toxicity. A role for Wnt signaling pathwayGinny G Farías, Juan A Godoy, Félix Hernández, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 2, 2018
AF710B, an M1/sigma-1 receptor agonist with long-lasting disease-modifying properties in a transgenic rat model of Alzheimer's diseaseHélène Hall, Maria Florencia Iulita, Palma Gubert, et al.
Neuron|March 1, 2006
M1 receptors play a central role in modulating AD-like pathology in transgenic miceAntonella Caccamo, Salvatore Oddo, Lauren M Billings, et al.
Journal of Alzheimer'S Disease : JAD|April 18, 2015
Acute Effects of Muscarinic M1 Receptor Modulation on AβPP Metabolism and Amyloid-β Levels in vivo: A Microdialysis StudyTobias Welt, Luka Kulic, Sarah E Hoey, et al.
Journal of Molecular Neuroscience : MN|September 6, 2002
AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's diseaseAbraham Fisher, Rachel Brandeis, Rachel Haring Nira Bar-Ner, et al.
Molecular and Cellular Neurosciences|August 30, 2008
Isoform-specific contribution of protein kinase C to prion processingMoustapha Alfa Cissé, Krystel Louis, Uschi Braun, et al.
EJNMMI Research|March 22, 2013
[11C]AF150(S), an agonist PET ligand for M1 muscarinic acetylcholine receptorsHans Jc Buiter, Albert D Windhorst, Marc C Huisman, et al.
Pageof 3